All News

As this year's installment of our Emerging Pharma Leaders shows, the current roadmap for a career in biopharma requires its own "Waze"-like navigation.

Click the title above to open the Pharmaceutical October 2018 issue in an interactive PDF format.

The regulator teams with other health agencies on strategies to combat antibiotic resistance, reshape R&D incentive schemes.

A look at the Drug SUpply Chain Security Act and how it impacts serialization and third-party logistics licensing.

To help combat the nation’s opioid epidemic, FDA is promoting a more tailored approach to developing and testing effective analgesics, with the aim of bringing less addictive pain treatments to market more quickly.

Faced with looming uncertainties triggered by the upcoming Brexit, the United Kingdom’s life sciences sector, which constitutes one of the last big remaining bastions of British industry, is not about to rest on its laurels.

Click the title above to open the Pharmaceutical Executive September 2018 issue in an interactive PDF format.